VANCOUVER, BC / ACCESS Newswire / January 22, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") is pleased to announce the completion of a study design fo ...

A new publication from CorriXR Therapeutics, an oncology focused biotherapeutics company developing genetic medicines to ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

Harrow, Inc. continues to execute on its branded ophthalmic portfolio, with Vevye and Iheezo outperforming expectations. Read ...

In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...

Building a diversion center is the first step toward breaking the chain of sorrow at the jail..

Lexaria now has 60 patents granted around much of the worldLexaria urges shareholders to vote at upcoming 2026 Annual Meeting KELOWNA, BC / ACCESS Newswire / January 22, 2026 / Lexaria Bioscience Corp ...

Wealth isn't just what you earn; it's also what you keep. Here are the money traps the financially savvy avoid at all costs.

By Tarun Sai Lomte From laboratory models to small human trials, a new review explores whether popular metabolic drugs could ...

GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...

In this week’s edition of The Prototype, we look at using AI to find new drugs, quantum biotechnology, the ROI of generative ...

The number of homicides in 35 large U.S. cities declined 21% from 2024 to 2025, according to a report released by the Council ...